Antiarrhythmic agents. II. Therapeutic considerations.
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000628:therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D001665:Binding Sites; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use; D004554:Electric Countershock; D006325:Heart Atria; D006352:Heart Ventricles; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010138:Pacemaker, Artificial; D011041:Poisoning / Q000188:drug therapy; D011188:Potassium / Q000097:blood
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D011188:Potassium